Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Crohn's
Sort By
Newest First
1 / 1
Bausch Health Companies Inc.
Crohn's
Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease
Bausch Health Companies Inc.
PR-M10-18-NI-106
Oct 31, 2018
Takeda
Real World Data
New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohn's Disease
Takeda
PR-M10-18-NI-034
Oct 10, 2018
1 / 1
